Stepwise-targeting and hypoxia-responsive liposome AMVY@NPs carrying siYAP and verteporfin for glioblastoma therapy
Ji Qi(Xuzhou Medical College), Xiuping Zhou(Xuzhou Medical College), Rutong Yu(Xuzhou Medical College), Long Zhang(Xuzhou Medical College), Jiahao Yu(Beijing University of Posts and Telecommunications), Zhongyu Ren(Xuzhou Medical College), Yan Wang(Karolinska University Hospital), Xu Wang(Western University), Yining Zhang(Xuzhou Medical College), Haoyue Xu(Xuzhou Medical College), Yi Yuan(Xuzhou Medical College), Linbo Gu(Xuzhou Medical College)
Cited by 20
Related Papers
TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway
|Journal of Experimental & Clinical Cancer Research|2018|156
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
|Cancer Cell|2018|155
The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients
|Scientific Reports|2021|143
Pleiotrophin: Activity and mechanism
|Advances in clinical chemistry|2020|112
Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
|International Journal of Nanomedicine|2017|95